Objectives: To determine similarities and differences in the reasons for using or not using complementary and alternative medicine (CAM) amongst general and condition-specific populations, and amongst populations in each region of the globe.
Methods: A literature search was performed on Pubmed, ScienceDirect and EMBASE.
Keywords: 'herbal medicine' OR 'herbal and dietary supplement' OR 'complementary and alternative medicine' AND 'reason' OR 'attitude'. Quantitative or qualitative original articles in English, published between 2003 and 2018 were reviewed. Conference proceedings, pilot studies, protocols, letters, and reviews were excluded. Papers were appraised using valid tools and a 'risk of bias' assessment was also performed. Thematic analysis was conducted. Reasons were coded in each paper, then codes were grouped into categories. If several categories reported similar reasons, these were combined into a theme. Themes were then analysed using χ tests to identify the main factors related to reasons for CAM usage.
Results: 231 publications were included. Reasons for CAM use amongst general and condition-specific populations were similar. The top three reasons for CAM use were: (1) having an expectation of benefits of CAM (84% of publications), (2) dissatisfaction with conventional medicine (37%) and (3) the perceived safety of CAM (37%). Internal health locus of control as an influencing factor was more likely to be reported in Western populations, whereas the social networks was a common factor amongst Asian populations (p < 0.05). Affordability, easy access to CAM and tradition were significant factors amongst African populations (p < 0.05). Negative attitudes towards CAM and satisfaction with conventional medicine (CM) were the main reasons for non-use (p < 0.05).
Conclusions: Dissatisfaction with CM and positive attitudes toward CAM, motivate people to use CAM. In contrast, satisfaction with CM and negative attitudes towards CAM are the main reasons for non-use.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686746 | PMC |
| http://dx.doi.org/10.1186/s12906-020-03157-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Barriers to cervical cancer screening among immigrant Yemeni women in Malaysia.
BMC Cancer
January 2025
Department of Community Health, Faculty of Medicine and Health Sciences, Taiz University, Taiz, 6803, Yemen.
Background: Cervical cancer is preventable cancer through pap test screening. Despite the benefits of cervical cancer screening, immigrant women have markedly lower use of Pap smear testing. Hence, this study aims to determine the barriers to cervical cancer screening among Yemeni female immigrants in Malaysia and the factors related to these barriers.
View Article and Find Full Text PDFTranslucency and contrast ratio of dimetharcyrlate resin based dental materials after bleaching: an in-vitro study.
BMC Oral Health
December 2024
Department of Restorative Dentistry, Faculty of Dentistry, Bolu Abant Izzet Baysal University, Bolu, Turkey.
Objective: To compare the translucency and contrast ratio of 13 different resin based restorative materials and to evaluate the effect of 2 different bleaching methods on the translucency and contrast ratio of these materials.
Methods: In this study, a total of 260 samples were prepared, 20 from each of 13 different dimethacrylate-based restorative materials. Then, each material group was divided into 4 subgroups.
Bonding super translucent multilayered monolithic zirconia to different foundation materials: an invitro study.
BMC Oral Health
December 2024
Department of Fixed Prosthodontics, Faculty of Dentistry, Mansoura University, Mansoura, Dakahlia Governorate, Egypt.
Background: The objective of this study was to investigate the effect of bonded substrate, zirconia surface conditioning and the interaction between them on the shear bond strength of monolithic zirconia.
Methods: Forty-eight monolithic zirconia discs were CAD-CAM fabricated and divided into two groups according to surface treatment either as milled and universal primer application (Monobond N, Ivoclar-Vivadent) (P) or sandblasting then universal primer application (Monobond N) (SP). Each main group was further divided into three test groups according to the bonded substrate: dentin (DSP, DP), composite (CSP, CP) or resin modified glass ionomer (RMGI) (GSP, GP).
Efficacy and Safety of CT-P13 as First- and Second-Line Treatment in Patients with Ankylosing Spondylitis.
J Clin Med
November 2024
Division of Rheumatology, School of Medicine, Dokuz Eylul University, 35220 Izmir, Turkey.
CT-P13 is a biosimilar version of infliximab, a monoclonal antibody. In individuals with ankylosing spondylitis (AS), CT-P13 has been shown to be effective and to have a well-tolerated safety profile. The aim of this study was to evaluate the long-term drug persistence, safety, and efficacy of infliximab biosimilar CT-P13 in patients with AS undergoing first-line (1st-line) and later (≥2nd-line) treatment in clinical practice.
View Article and Find Full Text PDFManagement of patients developing axillary pseudoaneursym after ductal stenting: Report of three cases.
Turk Gogus Kalp Damar Cerrahisi Derg
October 2024
Department of Pediatric Cardiology, University of Health Sciences, Başakşehir Çam ve Sakura City Hospital, Istanbul, Türkiye.
Pseudoaneurysms develop as a result of disruption of the arterial wall due to trauma or iatrogenic reasons such as catheterization, and it is important due to the high risk of bleeding and rupture. Until recently, the main treatment of pseudoaneurysms was surgical repair. However, in recent years, minimally invasive methods such as ultrasound-guided compression and percutaneous thrombin injection have been used more frequently.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!